Medical Care

Global Autologous Cell Therapy Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Autologous Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autologous Cell Therapy.
The Autologous Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Autologous Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autologous Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BioTime
Pharmicell
BrainStorm Cell Therapeutics
Opexa Therapeutics
Vericel Corporation
Regeneus
Segment by Type
Bone Marrow
Epidermis
Segment by Application
Neurology
Orthopedics
Cancer
Wound Healing
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autologous Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autologous Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Bone Marrow
1.2.3 Epidermis
1.3 Market by Application
1.3.1 Global Autologous Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Neurology
1.3.3 Orthopedics
1.3.4 Cancer
1.3.5 Wound Healing
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Autologous Cell Therapy Market Perspective (2020-2031)
2.2 Global Autologous Cell Therapy Growth Trends by Region
2.2.1 Global Autologous Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Autologous Cell Therapy Historic Market Size by Region (2020-2025)
2.2.3 Autologous Cell Therapy Forecasted Market Size by Region (2026-2031)
2.3 Autologous Cell Therapy Market Dynamics
2.3.1 Autologous Cell Therapy Industry Trends
2.3.2 Autologous Cell Therapy Market Drivers
2.3.3 Autologous Cell Therapy Market Challenges
2.3.4 Autologous Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autologous Cell Therapy Players by Revenue
3.1.1 Global Top Autologous Cell Therapy Players by Revenue (2020-2025)
3.1.2 Global Autologous Cell Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Autologous Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Autologous Cell Therapy Revenue
3.4 Global Autologous Cell Therapy Market Concentration Ratio
3.4.1 Global Autologous Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autologous Cell Therapy Revenue in 2024
3.5 Global Key Players of Autologous Cell Therapy Head office and Area Served
3.6 Global Key Players of Autologous Cell Therapy, Product and Application
3.7 Global Key Players of Autologous Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Autologous Cell Therapy Breakdown Data by Type
4.1 Global Autologous Cell Therapy Historic Market Size by Type (2020-2025)
4.2 Global Autologous Cell Therapy Forecasted Market Size by Type (2026-2031)
5 Autologous Cell Therapy Breakdown Data by Application
5.1 Global Autologous Cell Therapy Historic Market Size by Application (2020-2025)
5.2 Global Autologous Cell Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Autologous Cell Therapy Market Size (2020-2031)
6.2 North America Autologous Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Autologous Cell Therapy Market Size by Country (2020-2025)
6.4 North America Autologous Cell Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Autologous Cell Therapy Market Size (2020-2031)
7.2 Europe Autologous Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Autologous Cell Therapy Market Size by Country (2020-2025)
7.4 Europe Autologous Cell Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Autologous Cell Therapy Market Size (2020-2031)
8.2 Asia-Pacific Autologous Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Autologous Cell Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Autologous Cell Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Autologous Cell Therapy Market Size (2020-2031)
9.2 Latin America Autologous Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Autologous Cell Therapy Market Size by Country (2020-2025)
9.4 Latin America Autologous Cell Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autologous Cell Therapy Market Size (2020-2031)
10.2 Middle East & Africa Autologous Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Autologous Cell Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Autologous Cell Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BioTime
11.1.1 BioTime Company Details
11.1.2 BioTime Business Overview
11.1.3 BioTime Autologous Cell Therapy Introduction
11.1.4 BioTime Revenue in Autologous Cell Therapy Business (2020-2025)
11.1.5 BioTime Recent Development
11.2 Pharmicell
11.2.1 Pharmicell Company Details
11.2.2 Pharmicell Business Overview
11.2.3 Pharmicell Autologous Cell Therapy Introduction
11.2.4 Pharmicell Revenue in Autologous Cell Therapy Business (2020-2025)
11.2.5 Pharmicell Recent Development
11.3 BrainStorm Cell Therapeutics
11.3.1 BrainStorm Cell Therapeutics Company Details
11.3.2 BrainStorm Cell Therapeutics Business Overview
11.3.3 BrainStorm Cell Therapeutics Autologous Cell Therapy Introduction
11.3.4 BrainStorm Cell Therapeutics Revenue in Autologous Cell Therapy Business (2020-2025)
11.3.5 BrainStorm Cell Therapeutics Recent Development
11.4 Opexa Therapeutics
11.4.1 Opexa Therapeutics Company Details
11.4.2 Opexa Therapeutics Business Overview
11.4.3 Opexa Therapeutics Autologous Cell Therapy Introduction
11.4.4 Opexa Therapeutics Revenue in Autologous Cell Therapy Business (2020-2025)
11.4.5 Opexa Therapeutics Recent Development
11.5 Vericel Corporation
11.5.1 Vericel Corporation Company Details
11.5.2 Vericel Corporation Business Overview
11.5.3 Vericel Corporation Autologous Cell Therapy Introduction
11.5.4 Vericel Corporation Revenue in Autologous Cell Therapy Business (2020-2025)
11.5.5 Vericel Corporation Recent Development
11.6 Regeneus
11.6.1 Regeneus Company Details
11.6.2 Regeneus Business Overview
11.6.3 Regeneus Autologous Cell Therapy Introduction
11.6.4 Regeneus Revenue in Autologous Cell Therapy Business (2020-2025)
11.6.5 Regeneus Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Autologous Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Bone Marrow
Table 3. Key Players of Epidermis
Table 4. Global Autologous Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Autologous Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Autologous Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Autologous Cell Therapy Market Share by Region (2020-2025)
Table 8. Global Autologous Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Autologous Cell Therapy Market Share by Region (2026-2031)
Table 10. Autologous Cell Therapy Market Trends
Table 11. Autologous Cell Therapy Market Drivers
Table 12. Autologous Cell Therapy Market Challenges
Table 13. Autologous Cell Therapy Market Restraints
Table 14. Global Autologous Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Autologous Cell Therapy Market Share by Players (2020-2025)
Table 16. Global Top Autologous Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Cell Therapy as of 2024)
Table 17. Ranking of Global Top Autologous Cell Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Autologous Cell Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Autologous Cell Therapy, Headquarters and Area Served
Table 20. Global Key Players of Autologous Cell Therapy, Product and Application
Table 21. Global Key Players of Autologous Cell Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Autologous Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Autologous Cell Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global Autologous Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Autologous Cell Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global Autologous Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Autologous Cell Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global Autologous Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Autologous Cell Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America Autologous Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Autologous Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Autologous Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Autologous Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Autologous Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Autologous Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Autologous Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Autologous Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Autologous Cell Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Autologous Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Autologous Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Autologous Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Autologous Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Autologous Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Autologous Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. BioTime Company Details
Table 47. BioTime Business Overview
Table 48. BioTime Autologous Cell Therapy Product
Table 49. BioTime Revenue in Autologous Cell Therapy Business (2020-2025) & (US$ Million)
Table 50. BioTime Recent Development
Table 51. Pharmicell Company Details
Table 52. Pharmicell Business Overview
Table 53. Pharmicell Autologous Cell Therapy Product
Table 54. Pharmicell Revenue in Autologous Cell Therapy Business (2020-2025) & (US$ Million)
Table 55. Pharmicell Recent Development
Table 56. BrainStorm Cell Therapeutics Company Details
Table 57. BrainStorm Cell Therapeutics Business Overview
Table 58. BrainStorm Cell Therapeutics Autologous Cell Therapy Product
Table 59. BrainStorm Cell Therapeutics Revenue in Autologous Cell Therapy Business (2020-2025) & (US$ Million)
Table 60. BrainStorm Cell Therapeutics Recent Development
Table 61. Opexa Therapeutics Company Details
Table 62. Opexa Therapeutics Business Overview
Table 63. Opexa Therapeutics Autologous Cell Therapy Product
Table 64. Opexa Therapeutics Revenue in Autologous Cell Therapy Business (2020-2025) & (US$ Million)
Table 65. Opexa Therapeutics Recent Development
Table 66. Vericel Corporation Company Details
Table 67. Vericel Corporation Business Overview
Table 68. Vericel Corporation Autologous Cell Therapy Product
Table 69. Vericel Corporation Revenue in Autologous Cell Therapy Business (2020-2025) & (US$ Million)
Table 70. Vericel Corporation Recent Development
Table 71. Regeneus Company Details
Table 72. Regeneus Business Overview
Table 73. Regeneus Autologous Cell Therapy Product
Table 74. Regeneus Revenue in Autologous Cell Therapy Business (2020-2025) & (US$ Million)
Table 75. Regeneus Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
Table 79. Authors List of This Report


List of Figures
Figure 1. Autologous Cell Therapy Picture
Figure 2. Global Autologous Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Autologous Cell Therapy Market Share by Type: 2024 VS 2031
Figure 4. Bone Marrow Features
Figure 5. Epidermis Features
Figure 6. Global Autologous Cell Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Autologous Cell Therapy Market Share by Application: 2024 VS 2031
Figure 8. Neurology Case Studies
Figure 9. Orthopedics Case Studies
Figure 10. Cancer Case Studies
Figure 11. Wound Healing Case Studies
Figure 12. Others Case Studies
Figure 13. Autologous Cell Therapy Report Years Considered
Figure 14. Global Autologous Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Autologous Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Autologous Cell Therapy Market Share by Region: 2024 VS 2031
Figure 17. Global Autologous Cell Therapy Market Share by Players in 2024
Figure 18. Global Top Autologous Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Cell Therapy as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Autologous Cell Therapy Revenue in 2024
Figure 20. North America Autologous Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Autologous Cell Therapy Market Share by Country (2020-2031)
Figure 22. United States Autologous Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Autologous Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Autologous Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Autologous Cell Therapy Market Share by Country (2020-2031)
Figure 26. Germany Autologous Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Autologous Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Autologous Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Autologous Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Autologous Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Autologous Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Autologous Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Autologous Cell Therapy Market Share by Region (2020-2031)
Figure 34. China Autologous Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Autologous Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Autologous Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Autologous Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Autologous Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Autologous Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Autologous Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Autologous Cell Therapy Market Share by Country (2020-2031)
Figure 42. Mexico Autologous Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Autologous Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Autologous Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Autologous Cell Therapy Market Share by Country (2020-2031)
Figure 46. Turkey Autologous Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Autologous Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Autologous Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. BioTime Revenue Growth Rate in Autologous Cell Therapy Business (2020-2025)
Figure 50. Pharmicell Revenue Growth Rate in Autologous Cell Therapy Business (2020-2025)
Figure 51. BrainStorm Cell Therapeutics Revenue Growth Rate in Autologous Cell Therapy Business (2020-2025)
Figure 52. Opexa Therapeutics Revenue Growth Rate in Autologous Cell Therapy Business (2020-2025)
Figure 53. Vericel Corporation Revenue Growth Rate in Autologous Cell Therapy Business (2020-2025)
Figure 54. Regeneus Revenue Growth Rate in Autologous Cell Therapy Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies